关于 2024 年员工持股计划锁定期届满的提示性公告 证券代码：002458 证券简称：益生股份 公告编号：2025-051 山东益生种畜禽股份有限公司 关于 2024 年员工持股计划锁定期届满的 提示性公告 本公司及董事会全体成员保证信息披露内容真实、准确和完整， 没有虚假记载、误导性陈述或重大遗漏。 山东益生种畜禽股份有限公司（以下简称"公司"）2024 年员工 持股计划（以下简称"本员工持股计划"）锁定期将于 2025 年 7 月 16 日届满。根据《关于上市公司实施员工持股计划试点的指导意见》 《深 圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范 运作》及《山东益生种畜禽股份有限公司 2024 年员工持股计划管理 办法》的相关规定，现将本员工持股计划锁定期届满的相关情况公告 如下： 一、本员工持股计划的基本情况和锁定期 公司第六届董事会第十九次会议和 2024 年第三次临时股东大会 审议通过了公司《<2024 年员工持股计划（草案）>及摘要》相关议案， 同意公司实施本员工持股计划。具体内容详见公司于 2024 年 6 月 26 日及 2024 年 7 月 13 日刊登在《中国证券报》 ...

Core Viewpoint - The implementation of the 2025 employee stock ownership plan by Zhejiang Chengyi Pharmaceutical Co., Ltd. is expected to enhance the alignment of interests between employees and shareholders, improve employee motivation, and contribute to the company's long-term sustainable development [1][2]. Summary by Sections Employee Stock Ownership Plan - The 2025 employee stock ownership plan aims to establish and improve the mechanism for sharing interests between employees and shareholders, thereby enhancing the company's competitiveness and cohesion among employees [1]. - The draft of the 2025 employee stock ownership plan complies with relevant regulations and does not harm the interests of the company or all shareholders [1]. - Participation in the employee stock ownership plan is based on voluntary compliance, with no forced participation or distribution among employees [1].

Meeting Overview - The company held the 11th meeting of the 3rd Employee Representative Assembly on July 12, 2025, to solicit opinions on the proposed 2025 Employee Stock Ownership Plan [1] - The meeting complied with relevant regulations including the Company Law of the People's Republic of China and the Shanghai Stock Exchange's self-regulatory guidelines [1] Employee Stock Ownership Plan - The purpose of the 2025 Employee Stock Ownership Plan is to establish a profit-sharing mechanism between employees and shareholders, improve corporate governance, enhance employee cohesion, and promote long-term sustainable development [1] - The plan is designed to ensure that employee participation is voluntary, compliant with laws, and that risks are borne by the employees themselves [2] - The plan has received unanimous approval from all employee representatives and will be submitted for further review by the company's board of directors and shareholders' meeting [2]

Core Viewpoint - The legal opinion letter from Anhui Tianhe Law Office confirms that Tongxing Environmental Technology Co., Ltd. is legally qualified to implement its 2025 Employee Stock Ownership Plan (ESOP) and that the plan complies with relevant laws and regulations [1][14]. Group 1: Company Qualifications - Tongxing Environmental Technology Co., Ltd. is a legally established and effectively operating listed company, with no circumstances requiring termination under relevant laws and regulations [6][14]. - The company holds a business license with a registered capital of 130.7232 million RMB and operates in various sectors including environmental protection equipment manufacturing and energy technology research [5][14]. Group 2: Legality and Compliance of the Employee Stock Ownership Plan - The ESOP has been approved by the China Securities Regulatory Commission and complies with the guidelines set forth in the Trial Guidance and the Self-Regulatory Guidelines for Listed Companies [4][14]. - The plan adheres to principles of legality, voluntary participation, and risk-bearing, ensuring no forced participation or insider trading [7][8][14]. Group 3: Procedures and Information Disclosure - The company has completed necessary procedures for the ESOP, including board resolutions and employee consultations, and is awaiting approval from the shareholders' meeting [11][12][14]. - The company has fulfilled its information disclosure obligations regarding the ESOP and will continue to do so as the plan progresses [12][13][14].

Core Viewpoint - The company has developed a draft for the 2025 Employee Stock Ownership Plan (ESOP) in compliance with relevant laws and regulations, ensuring it aligns with the guidelines set forth by the regulatory authorities [1][2]. Summary by Sections Compliance with Regulations - The company confirms that there are no prohibitive circumstances under the relevant laws and regulations for implementing the ESOP [1]. - The content of the ESOP aligns with the guidelines and regulations stipulated in the relevant legal documents [1][2]. Governance and Procedures - The plan has been approved with the avoidance of conflicts of interest, as related directors and supervisors have recused themselves from voting, ensuring the process is legal and effective [1]. - There are no forced participation methods such as compulsory allocation for employees in this ESOP [1]. Eligibility and Financial Support - The designated participants of the ESOP meet the eligibility criteria outlined in the relevant guidelines, ensuring their qualifications are legitimate and valid [2]. - The company does not have any plans to provide loans, guarantees, or other financial assistance to the participants of the ESOP [2]. Benefits of the ESOP - The ESOP is expected to enhance the company's governance, improve the compensation and incentive mechanisms, and motivate employees, contributing to the long-term sustainable development of the company [2].

Core Viewpoint - The company’s remuneration and assessment committee has reviewed the 2025 employee stock ownership plan, concluding that it will not harm the interests of the company or its shareholders, particularly minority shareholders, and aligns with the company's long-term development needs [1][2]. Summary by Relevant Sections - The committee confirmed that the decision-making process for the employee stock ownership plan is legal and effective, ensuring no harm to the company or shareholders, and that participation is not forced [1]. - The plan meets the eligibility criteria set forth in relevant regulations, ensuring that the participants are legally qualified [1]. - The implementation of the employee stock ownership plan is expected to enhance employee cohesion and company competitiveness, aligning the interests of management and shareholders, thereby improving management efficiency and responsibility, which is beneficial for the company's sustainable development and strategic goals [1].

Core Viewpoint - Jiangsu Hualan Pharmaceutical New Materials Co., Ltd. plans to repurchase its shares using raised funds, self-owned funds, and self-raised funds, with a total repurchase amount between RMB 100 million and RMB 200 million, aimed at capital reduction and employee stock ownership plans [1][2][16]. Summary by Sections Repurchase Funding Sources - The total repurchase amount will not be less than RMB 100 million and not exceed RMB 200 million, with raised funds between RMB 30 million and RMB 60 million, and self-owned and self-raised funds between RMB 70 million and RMB 140 million [1][16]. Purpose of Repurchase - The repurchased shares will be used for capital reduction and employee stock ownership plans or equity incentives. Shares bought with raised funds will be canceled, while those bought with self-owned and self-raised funds may be used for employee incentives in the future [1][13][16]. Types and Methods of Shares to be Repurchased - The shares to be repurchased are ordinary shares (A shares) and will be acquired through centralized bidding [2][12]. Repurchase Timeline and Price - The repurchase period will not exceed 12 months from the date of the shareholders' meeting approval, with a maximum price of RMB 45.50 per share [2][15]. Shareholder Reduction Plans - Major shareholder Ruizhong Life Insurance Co., Ltd. plans to reduce its holdings by up to 3,789,267 shares (3.00% of total shares) between June 4, 2025, and September 3, 2025 [2][20]. Financial Impact and Company Structure - As of March 31, 2025, the total assets of the company were approximately RMB 2.51 billion, and the repurchase funds will account for about 7.98% of total assets and 8.83% of equity attributable to shareholders [17][22]. Compliance and Approval - The repurchase plan has been approved by the board and will comply with relevant laws and regulations, ensuring it does not harm the interests of the company or its shareholders [26][27].

Core Viewpoint - The company has launched a 2025 employee stock ownership plan aimed at enhancing talent retention and driving long-term growth through performance-based incentives [1][2]. Group 1: Employee Stock Ownership Plan - The employee stock ownership plan covers a wide range of participants, including directors (excluding independent directors), supervisors, senior management, middle management, and core employees, totaling up to 358 individuals, with 16.45% of shares allocated to directors and senior management [2]. - The plan has a duration of 36 months, with performance targets tied to both company-wide and individual performance metrics. The first 50% of shares can be unlocked after 12 months if the company's net profit reaches at least 1.3 billion RMB, with a tiered unlocking mechanism based on performance [2]. - The total amount of employee self-funded capital is capped at 163.99 million RMB, with a share price set at 15.78 RMB per share [1][2]. Group 2: Business Expansion and Market Position - The company has achieved a 40%-50% market share in the domestic new energy market for its drive gear products, with significant order growth attributed to its high-performance coaxial reducers [3]. - The company is accelerating the construction of its Hungary facility to cater to European market demands, aiming to enhance its influence and market share in Europe through localized production [3]. - The company is a leader in precision drive systems and is expanding its global footprint while developing intelligent drive mechanisms and robotic joint businesses, indicating strong long-term growth potential [5]. Group 3: Financial Projections - Revenue projections for 2025-2027 are estimated at 10.47 billion RMB, 12.47 billion RMB, and 14.96 billion RMB, respectively, with corresponding net profits of 1.30 billion RMB, 1.52 billion RMB, and 1.89 billion RMB [7]. - The expected growth rates for revenue are 19.2% in 2025, 19.1% in 2026, and 20.0% in 2027, while net profit growth rates are projected at 27.2%, 16.8%, and 24.4% for the same years [7]. - Earnings per share (EPS) are forecasted to be 1.54 RMB in 2025, 1.79 RMB in 2026, and 2.23 RMB in 2027, with corresponding price-to-earnings (PE) ratios of 20, 17, and 14 [7].

Meeting Overview - The first meeting of the 2025 Employee Stock Ownership Plan (ESOP) was held on July 11, 2025, both in-person and via communication methods, with 100% attendance from the holders [1] - The meeting was convened and presided over by the company's board secretary, ensuring compliance with the relevant regulations of the ESOP [1] Resolutions Passed - A management committee was established to oversee the ESOP, consisting of three members, with a term aligned with the duration of the ESOP [1][2] - The committee members elected were Xiong Wenquan, He Zhiliang, and Li Lele, all of whom do not hold more than 5% of the company's shares and have no related party relationships with major stakeholders [2] Committee Responsibilities - The management committee is authorized to handle various tasks, including convening meetings, supervising daily management, managing accounts, and representing holders in exercising shareholder rights [3][4] - The committee will also manage the assets of the ESOP, coordinate with professional consulting institutions, and handle matters related to the registration and distribution of benefits [3][4]

Meeting Overview - The first meeting of the 2025 Employee Stock Ownership Plan (ESOP) was held on July 11, 2025, with 113 attendees representing 7,098,000 shares, which is 100% of the total shares in the plan [1] Resolutions Passed - The establishment of the 2025 ESOP Management Committee was approved to ensure the orderly implementation of the plan and protect the rights of the holders [2] - The election of Mr. Qu Xianwei, Mr. Zhou Wei, and Mr. Wu Yuanjie as members of the Management Committee was approved, with their terms aligned with the duration of the ESOP [2] - The Management Committee was authorized to handle all matters related to the ESOP, including equity distribution and refinancing matters, with a stipulation for the sale of shares within 12 months post-lock-up period [3]